Universidad Peruana Cayetano Heredia

Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: Barriers and facilitators to pre-exposure prophylaxis uptake among at-risk peruvian populations

Mostrar el registro sencillo del ítem

dc.contributor.author Galea, J.T.
dc.contributor.author Kinsler, J.J.
dc.contributor.author Salazar Lostaunau, Ximena
dc.contributor.author Lee, S.-J.
dc.contributor.author Giron, M.
dc.contributor.author Sayles, J.N.
dc.contributor.author Caceres Palacios, Carlos Fernando
dc.contributor.author Cunningham, W.E.
dc.date.accessioned 2022-01-18T19:34:36Z
dc.date.available 2022-01-18T19:34:36Z
dc.date.issued 2011
dc.identifier.uri https://hdl.handle.net/20.500.12866/11054
dc.description.abstract Summary: This study examined pre-exposure prophylaxis (PrEP) acceptability among female sex workers, male-to-female transgendered persons and men who have sex with men in Lima, Peru. Focus groups explored social issues associated with PrEP acceptability and conjoint analysis assessed preferences among eight hypothetical PrEP scenarios with varying attribute profiles and their relative impact on acceptability. Conjoint analysis revealed that PrEP acceptability ranged from 19.8 to 82.5 out of a possible score of 100 across the eight hypothetical PrEP scenarios. Out-of-pocket cost had the greatest impact on PrEP acceptability (25.2, P, 0.001), followed by efficacy (21.4, P, 0.001) and potential side-effects (14.7, P, 0.001). Focus group data supported these findings, and also revealed that potential sexual risk disinhibition, stigma and discrimination associated with PrEP use, and mistrust of health-care professionals were also concerns. These issues will require careful attention when planning for PrEP roll-out. en_US
dc.language.iso eng
dc.publisher SAGE Publications
dc.relation.ispartofseries International Journal of STD and AIDS
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Humans en_US
dc.subject Peru en_US
dc.subject risk assessment en_US
dc.subject article en_US
dc.subject controlled study en_US
dc.subject major clinical study en_US
dc.subject priority journal en_US
dc.subject population research en_US
dc.subject South America en_US
dc.subject drug efficacy en_US
dc.subject nausea en_US
dc.subject HIV Infections en_US
dc.subject Homosexuality, Male en_US
dc.subject MSM en_US
dc.subject Human immunodeficiency virus infection en_US
dc.subject prostitution en_US
dc.subject Focus Groups en_US
dc.subject HIV en_US
dc.subject Prostitution en_US
dc.subject transsexualism en_US
dc.subject male homosexual en_US
dc.subject social aspect en_US
dc.subject health care personnel en_US
dc.subject antivirus agent en_US
dc.subject high risk population en_US
dc.subject awareness en_US
dc.subject cost benefit analysis en_US
dc.subject prophylaxis en_US
dc.subject Patient Acceptance of Health Care en_US
dc.subject dizziness en_US
dc.subject Acceptability en_US
dc.subject Chemoprevention en_US
dc.subject FSW en_US
dc.subject Pre-exposure prophylaxis (PrEP) en_US
dc.subject Transvestism en_US
dc.title Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: Barriers and facilitators to pre-exposure prophylaxis uptake among at-risk peruvian populations en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1258/ijsa.2009.009255
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.03.08
dc.relation.issn 1758-1052


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas